Showing results (41-50 of 204) with videos related to
Sort By:
Pageof 21
In Vivo (Athens, Greece)|July 10, 2008
A study of immunoendocrine strategies with pineal indoles and interleukin-2 to prevent radiotherapy-induced lymphocytopenia in cancer patientsP Lissoni, F Rovelli, F Brivio, et al.Natural Immunity|October 28, 1998
Circadian secretions of IL-2, IL-12, IL-6 and IL-10 in relation to the light/dark rhythm of the pineal hormone melatonin in healthy humansP Lissoni, F Rovelli, F Brivio, et al.Anticancer Research|April 13, 2001
A phase II study of subcutaneous low-dose interleukin-2 plus erythropoietin in metastatic renal cell carcinoma progressing on interleukin-2 aloneP Lissoni, F Rovelli, N Baiocco, et al.Tumori|November 1, 1995
Endocrine effects of granulocyte colony-stimulating factor in cancer patientsF Rovelli, S Barni, G Tancini, et al.Giornale Italiano Di Cardiologia|January 1, 1983
[Malignant ventricular hyperkinetic arrhythmias. Classificational criteria: review of Lown's classification. Polycentric study]B Brusoni, G Sanna, R Bettini, et al.Arzneimittel-Forschung|January 1, 1979
Acute clinical tolerance of creatinol O-phosphateG F Melloni, G M Minoja, G F Lureti, et al.Oncology Reports|May 20, 2011
Modulation of cytokine production from TH2-lymphocytes and monocytes by the pineal neurohormone melatoninP Lissoni, S Pittalis, F Rovelli, et al.Natural Immunity|November 4, 2000
Immunomodulatory effects of IL-12 in relation to the pineal endocrine function in metastatic cancer patientsP Lissoni, F Rovelli, L Giani, et al.Journal of Pineal Research|April 1, 1992
Normalization of the light/dark rhythm of melatonin after prolonged subcutaneous administration of interleukin-2 in advanced small cell lung cancer patientsS Viviani, P Bidoli, S Spinazzé, et al.Natural Immunity|October 28, 1998
Biotherapy with the pineal immunomodulating hormone melatonin versus melatonin plus aloe vera in untreatable advanced solid neoplasmsP Lissoni, L Giani, S Zerbini, et al.Pageof 21